Sio Capital Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Sio Capital Management’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-60,220	Closed	-$240K	–	81
2022 Q1	$240K	Sell	60,220 -19,744	-25%	-$103K	0.08%	58
2021 Q4	$680K	Sell	79,964 -238,635	-75%	-$2.37M	0.21%	59
2021 Q3	$3.61M	Sell	318,599 -224,378	-41%	-$2.69M	1.15%	28
2021 Q2	$5.53M	Buy	542,977 +52,989	+11%	+$544K	1.38%	23
2021 Q1	$5.35M	Buy	489,988 +333,333	+213%	+$4.76M	1.09%	31
2020 Q4	$1.72M	Sell	156,655 -3,311	-2%	-$38.2K	0.35%	69
2020 Q3	$1.84M	Buy	159,966 +45,420	+40%	+$531K	0.37%	61
2020 Q2	$1.16M	Buy	+114,546	New	+$1.59M	0.34%	60

Other funds holding AYLA

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

DAM

DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sio Capital Management's AYLA Position: Q2 2022 in Review

Sio Capital Management sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q2 2022, closing a stake of 60,220 shares — an estimated $240K sold.

Sio Capital Management first reported a position in AYLA in Q2 2020 and held it in 8 quarters. The position peaked at $5.53M in Q2 2021. 15 funds tracked by Wall St. Rank hold AYLA as of Q2 2022.

Sio Capital Management reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Sio Capital Management sold 60,220 Ayala Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $240K.
Sio Capital Management first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Sio Capital Management's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $5.53M in Q2 2021.
15 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.